Sunflower Pharmaceuticals Group Co Ltd (002737) - Total Liabilities

Latest as of March 2026: CN¥1.25 Billion CNY ≈ $182.79 Million USD

Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has total liabilities worth CN¥1.25 Billion CNY (≈ $182.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sunflower Pharmaceuticals Group Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Sunflower Pharmaceuticals Group Co Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 002737 total asset value.

Sunflower Pharmaceuticals Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Seneca Foods Corp A NASDAQ:SENEA	USA	$488.31 Million
Bank Tabungan Negara Persero JK:BBTN	Indonesia	Rp507.60 Trillion
Emerald Expositions Events Inc NYSE:EEX	USA	$847.80 Million
Hangzhou Jingye Intelligent Technology Co. Ltd. A SHG:688290	China	CN¥493.75 Million
Shantou Wanshun Package Material SHE:300057	China	CN¥5.99 Billion
Supalai Public Company Limited BK:SPALI	Thailand	฿46.67 Billion
Phoenix Education Partners, Inc. NYSE:PXED	USA	$282.21 Million
China Reform Health Management and Services Group Co Ltd SHE:000503	China	CN¥789.38 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Sunflower Pharmaceuticals Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Sunflower Pharmaceuticals Group Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sunflower Pharmaceuticals Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)

The table below shows the annual total liabilities of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.34 Billion ≈ $195.74 Million	+8.23%
2024-12-31	CN¥1.24 Billion ≈ $180.85 Million	-34.16%
2023-12-31	CN¥1.88 Billion ≈ $274.70 Million	-27.60%
2022-12-31	CN¥2.59 Billion ≈ $379.44 Million	+52.52%
2021-12-31	CN¥1.70 Billion ≈ $248.78 Million	-1.31%
2020-12-31	CN¥1.72 Billion ≈ $252.07 Million	-8.36%
2019-12-31	CN¥1.88 Billion ≈ $275.05 Million	+15.87%
2018-12-31	CN¥1.62 Billion ≈ $237.38 Million	+23.97%
2017-12-31	CN¥1.31 Billion ≈ $191.49 Million	-7.80%
2016-12-31	CN¥1.42 Billion ≈ $207.68 Million	+22.97%
2015-12-31	CN¥1.15 Billion ≈ $168.89 Million	-20.59%
2014-12-31	CN¥1.45 Billion ≈ $212.67 Million	+18.20%
2013-12-31	CN¥1.23 Billion ≈ $179.92 Million	+8.23%
2012-12-31	CN¥1.14 Billion ≈ $166.24 Million	+12.08%
2011-12-31	CN¥1.01 Billion ≈ $148.33 Million	--

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$961.40 Million

CN¥6.57 Billion CNY

Market Cap Rank

#9141 Global

#2269 in China

Share Price

CN¥11.25

Change (1 day)

+0.27%

52-Week Range

CN¥11.21 - CN¥15.62

All Time High

CN¥28.79